Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 217

1.

Complications from Surgeries Related to Ovarian Cancer Screening.

Baldwin LA, Pavlik EJ, Ueland E, Brown HE, Ladd KM, Huang B, DeSimone CP, van Nagell JR, Ueland FR, Miller RW.

Diagnostics (Basel). 2017 Mar 8;7(1). pii: E16. doi: 10.3390/diagnostics7010016.

2.

Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer.

Lefringhouse JR, Elder JW, Baldwin LA, Miller RW, DeSimone CP, van Nagell JR Jr, Samoyoa LM, West DS, Dressler EV, Liu M, Ueland FR.

Gynecol Oncol. 2017 Apr;145(1):50-54. doi: 10.1016/j.ygyno.2017.01.032. Epub 2017 Feb 9.

PMID:
28190648
3.

Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy.

Xu B, Lefringhouse J, Liu Z, West D, Baldwin LA, Ou C, Chen L, Napier D, Chaiswing L, Brewer LD, St Clair D, Thibault O, van Nagell JR, Zhou BP, Drapkin R, Huang JA, Lu ML, Ueland FR, Yang XH.

Oncogenesis. 2017 Jan 30;6(1):e295. doi: 10.1038/oncsis.2016.86.

4.

Probability of fallopian tube and ovarian detection with transvaginal ultrasonography in normal women.

Lefringhouse JR, Neward E, Ueland FR, Baldwin LA, Miller RW, DeSimone CP, Kryscio RJ, van Nagell JR, Pavlik EJ.

Womens Health (Lond). 2016 Jun;12(3):303-11. doi: 10.2217/whe.15.111. Epub 2016 May 18.

5.

Evaluation and Management of Ultrasonographically Detected Ovarian Tumors in Asymptomatic Women.

van Nagell JR Jr, Miller RW.

Obstet Gynecol. 2016 May;127(5):848-58. doi: 10.1097/AOG.0000000000001384.

PMID:
27054927
6.

Ultrasound follow up of an adnexal mass has the potential to save lives.

Ormsby EL, Pavlik EJ, van Nagell JR.

Am J Obstet Gynecol. 2015 Nov;213(5):657-61, 657.e1. doi: 10.1016/j.ajog.2015.06.041. Epub 2015 Jun 23.

PMID:
26116103
7.

CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling.

Baldwin LA, Hoff JT, Lefringhouse J, Zhang M, Jia C, Liu Z, Erfani S, Jin H, Xu M, She QB, van Nagell JR, Wang C, Chen L, Plattner R, Kaetzel DM, Luo J, Lu M, West D, Liu C, Ueland FR, Drapkin R, Zhou BP, Yang XH.

Oncotarget. 2014 Dec 15;5(23):12203-17.

8.

Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer.

Hoff J, Baldwin L, Lefringhouse J, Pavlik E, Miller R, DeSimone C, Ueland F, Tucker T, Kryscio R, van Nagell JR.

J Oncol. 2014;2014:312193. doi: 10.1155/2014/312193. Epub 2014 Sep 1.

9.

Serial ultrasonographic evaluation of ovarian abnormalities with a morphology index.

Elder JW, Pavlik EJ, Long A, Miller RW, DeSimone CP, Hoff JT, Ueland WR, Kryscio RJ, van Nagell JR Jr, Ueland FR.

Gynecol Oncol. 2014 Oct;135(1):8-12. doi: 10.1016/j.ygyno.2014.07.091. Epub 2014 Jul 25.

PMID:
25068975
10.

Transvaginal ultrasonography in ovarian cancer screening: current perspectives.

van Nagell JR Jr, Hoff JT.

Int J Womens Health. 2013 Dec 20;6:25-33. doi: 10.2147/IJWH.S38347. Review.

11.

Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography.

Pavlik EJ, Ueland FR, Miller RW, Ubellacker JM, DeSimone CP, Elder J, Hoff J, Baldwin L, Kryscio RJ, van Nagell JR Jr.

Obstet Gynecol. 2013 Aug;122(2 Pt 1):210-7. doi: 10.1097/AOG.0b013e318298def5.

PMID:
23969786
12.

Ovarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms.

Skaggs HS, Saunders BA, Miller RW, Goodrich ST, King MS, Kimbler KD, Branscum AJ, Fung ET, DePriest PD, van Nagell JR, Ueland FR, Baron AT.

Cancer Invest. 2013 Aug;31(7):433-53. doi: 10.3109/07357907.2013.802799.

PMID:
23915068
13.

Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer.

Podzielinski I, Saunders BA, Kimbler KD, Branscum AJ, Fung ET, DePriest PD, van Nagell JR, Ueland FR, Baron AT.

Cancer Invest. 2013 May;31(4):258-72. doi: 10.3109/07357907.2013.789896.

PMID:
23627408
14.

Early detection of ovarian tumors using ultrasound.

Pavlik EJ, van Nagell JR Jr.

Womens Health (Lond). 2013 Jan;9(1):39-55; quiz 56-7. doi: 10.2217/whe.12.62.

15.

Ten-year relative survival for epithelial ovarian cancer.

Baldwin LA, Huang B, Miller RW, Tucker T, Goodrich ST, Podzielinski I, DeSimone CP, Ueland FR, van Nagell JR, Seamon LG.

Obstet Gynecol. 2012 Sep;120(3):612-8.

PMID:
22914471
16.

Ovarian cancer screening--what women want.

Pavlik EJ, van Nagell JR Jr.

Int J Gynecol Cancer. 2012 May;22 Suppl 1:S21-3. doi: 10.1097/IGC.0b013e318251cbc2.

PMID:
22543915
17.

Ovarian cancer screening.

van Nagell JR Jr, Pavlik EJ.

Clin Obstet Gynecol. 2012 Mar;55(1):43-51. doi: 10.1097/GRF.0b013e3182460c0d. Review.

PMID:
22343228
18.

Ovarian cancer. Foreword.

van Nagell JR Jr, Copeland LJ.

Clin Obstet Gynecol. 2012 Mar;55(1):1-2. doi: 10.1097/GRF.0b013e31824c686b. No abstract available.

PMID:
22343224
19.

Selective inguinal lymphadenectomy in the treatment of invasive squamous cell carcinoma of the vulva.

Desimone CP, Elder J, van Nagell JR Jr.

Int J Surg Oncol. 2011;2011:284374. doi: 10.1155/2011/284374. Epub 2011 Jun 9.

20.

Early detection of ovarian cancer in symptomatic women.

van Nagell JR Jr.

Lancet Oncol. 2012 Mar;13(3):223-4. doi: 10.1016/S1470-2045(11)70405-3. Epub 2012 Jan 17. No abstract available.

PMID:
22257525

Supplemental Content

Loading ...
Support Center